Macaca < Macaca fascicularis < Macaca mulatta

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]

Ident.	Authors (with country if any)	Title
000439 (2014)	Jay S. Schneider [États-Unis] ; Mark E. Ault ; David W. Anderson	Retinal pathology detected by optical coherence tomography in an animal model of Parkinson's disease.
000559 (2014)	Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. Facheris	Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.
000A93 (2013)	Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta	Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
000B37 (2013)	Jay S. Schneider [États-Unis] ; Elsa Y. Pioli ; Yang Jianzhong ; Qin Li ; Erwan Bezard	Levodopa improves motor deficits but can further disrupt cognition in a macaque Parkinson model.
001327 (2011)	James B. Koprich [Canada] ; Susan H. Fox ; Tom H. Johnston ; Allan Goodman ; Bertrand Le Bourdonnec ; Roland E. Dolle ; Robert N. Dehaven ; Diane L. Dehaven-Hudkins ; Patrick J. Little ; Jonathan M. Brotchie	The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease.
001565 (2010)	Tom H. Johnston [Canada] ; Susan H. Fox ; Matthew J. Piggott ; Juha-Matti Savola ; Jonathan M. Brotchie	The α₂ adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates.
001874 (2010)	Tom H. Johnston [Canada] ; Anne Van Der Meij ; Jonathan M. Brotchie ; Susan H. Fox	Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease.
001A55 (2010)	Pershia Samadi [Canada] ; Marc Morissette ; Daniel Lévesque ; Thérèse Di Paolo	BDNF levels are not related with levodopa-induced dyskinesias in MPTP monkeys.
001C57 (2009)	Glenda Halliday [Australie] ; Maria Trinidad Herrero ; Karen Murphy ; Heather Mccann ; Francisco Ros-Bernal ; Carlos Barcia ; Hideo Mori ; Francisco J. Blesa ; José A. Obeso	No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism.
002356 (2008)	Jose L. Lanciego [Espagne] ; Maria C. Rodríguez-Oroz ; Francisco J. Blesa ; Lydia Alvarez-Erviti ; Jorge Guridi ; Pedro Barroso-Chinea ; Yoland Smith ; Jose A. Obeso	Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys.
002E91 (2006)	Marc Morissette [Canada] ; Mehdi Dridi ; Frédéric Calon ; Abdallah Hadj Tahar ; Leonard T. Meltzer ; Paul J. Bédard ; Thérèse Di Paolo	Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
002F35 (2005)	Pierre-Olivier Fernagut [États-Unis] ; Imad Ghorayeb ; Elsa Diguet ; François Tison	In vivo models of multiple system atrophy.
003035 (2005)	Pershia Samadi [Canada] ; Laurent Grégoire ; Arash Rassoulpour ; Paolo Guidetti ; Emanuela Izzo ; Robert Schwarcz ; Paul J. Bédard	Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys.
003609 (2003)	Nancy Bélanger [Canada] ; Laurent Grégoire ; Abdallah Hadj Tahar ; Paul J. Bédard	Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys.
003876 (2003)	Jay S. Schneider [États-Unis] ; Timothy V. Wade	Experimental parkinsonism is associated with increased pallidal GAD gene expression and is reversed by site-directed antisense gene therapy.
003F72 (2000)	I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; W. Poewe ; G K Wenning ; F. Tison	Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
004357 (1998)	P J Blanchet [États-Unis] ; S. Konitsiotis ; T N Chase	Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
004383 (1998)	J S Schneider [États-Unis] ; A. Pope-Coleman ; M. Van Velson ; F. Menzaghi ; G K Lloyd	Effects of SIB-1508Y, a novel neuronal nicotinic acetylcholine receptor agonist, on motor behavior in parkinsonian monkeys.
004712 (1997)	L. Rioux [États-Unis] ; P A Frohna ; J N Joyce ; J S Schneider	The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
004880 (1996)	P J Blanchet [Canada] ; R. Grondin ; P J Bédard	Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.
004C16 (1993)	M. Guttman [Canada] ; G. Léger ; A. Reches ; A. Evans ; H. Kuwabara ; J M Cedarbaum ; A. Gjedde	Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Macaca fascicularis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Macaca fascicularis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Macaca fascicularis
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024